Inc. MGNX,This biopharmaceutical company specialises in the development of various antibody-based cancer treatments, including a number that are currently in clinical trials.
Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| MacroGenics, Inc. - MGNX - Share chat | 0 | 70 | 1 February 2024 | |
| Athenex | 0 | 321 | 10 November 2020 | |
| Kadmon Holdings Inc KDMN | 0 | 351 | 10 November 2020 | |
| MannKind Corp. MNKD | 0 | 365 | 10 November 2020 | |
| BioMarin Pharmaceutical Inc BMRN | 0 | 405 | 10 November 2020 |